XML 129 R53.htm IDEA: XBRL DOCUMENT v3.20.1
Parent Company Only Financial Information (Tables)
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Schedule of Condensed Balance Sheet

 

 

 

 

 

 

 

Condensed Balance Sheets

 

December 31, 

Assets

 

2019

 

2018

Cash and due from banks

 

$

5,568

 

$

7,026

Investment in subsidiary

 

 

204,570

 

 

182,874

Other assets

 

 

172

 

 

175

Total assets

 

$

210,310

 

$

190,075

Liabilities and Stockholders' Equity

 

 

 

 

 

  

Subordinated note, net

 

 

9,885

 

 

9,865

Other liabilities

 

 

183

 

 

172

Total liabilities

 

 

10,068

 

 

10,037

Stockholders' equity

 

 

200,242

 

 

180,038

Total liabilities and stockholders' equity

 

$

210,310

 

$

190,075

 

Schedule of Condensed Statements of Income

 

 

 

 

 

 

 

Condensed Statements of Income

 

Year Ended December 31, 

 

    

2019

    

2018

Interest from subsidiary

 

$

 2

 

$

 2

Interest expense on subordinated note

 

 

(679)

 

 

(679)

Dividends received from subsidiary

 

 

3,935

 

 

1,436

Other expenses

 

 

(142)

 

 

(157)

Income before income tax benefit and equity in undistributed net income of subsidiary

 

 

3,116

 

 

602

Income tax benefit

 

 

172

 

 

175

Equity in undistributed earnings of subsidiary

 

 

19,429

 

 

23,570

Net income

 

$

22,717

 

$

24,347

 

Schedule of Condensed Statements of Cash Flows

 

 

 

 

 

 

 

Condensed Statements of Cash Flows

     

Year Ended December 31, 

 

    

2019

     

2018

Cash flows from operating activities:

 

 

 

 

 

 

Net income

 

$

22,717

 

$

24,347

Equity in undistributed net income of subsidiary

 

 

(19,429)

 

 

(23,570)

Amortization

 

 

20

 

 

20

ESOP compensation expense for allocated shares

 

 

1,231

 

 

940

Share-based compensation expense related to stock options and restricted stock

 

 

869

 

 

767

Other assets

 

 

 3

 

 

115

Other liabilities

 

 

11

 

 

 6

Net cash from operating activities

 

 

5,422

 

 

2,625

Cash flows from investing activities:

 

 

  

 

 

 

Net proceeds from ESOP

 

 

275

 

 

269

Net cash from investing activities

 

 

275

 

 

269

Cash flows (used by) from financing activities:

 

 

  

 

 

 

Proceeds from stock options exercised

 

 

705

 

 

1,117

Common stock repurchased for employee/director taxes paid on restricted stock awards

 

 

(204)

 

 

(251)

Common stock repurchased

 

 

(4,800)

 

 

 —

Dividends paid on common stock

 

 

(2,856)

 

 

(1,915)

Net cash (used by) from financing activities

 

 

(7,155)

 

 

(1,049)

Net (decrease) increase in cash and cash equivalents

 

 

(1,458)

 

 

1,845

Cash and cash equivalents, beginning of year

 

 

7,026

 

 

5,181

Cash and cash equivalents, end of year

 

$

5,568

 

$

7,026